Akba stock forecast
AKBA shares had a relatively better volume day versus average trading capacity of 1.49 million shares, but with a 0.11 billion float and a -3.16% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for AKBA stock indicates that the average analyst price target is $14.59 per share. Akebia: Is This A Potential Winner? - Akebia Therapeutics ... Jan 11, 2019 · The current bear market offers many high-quality companies that are on sales at a deep bargain. As we continue our bargain-hunting quest, we stumbled upon Akebia Therapeutics. 5 “Strong Buy” Biotech Stocks With More Than 80% Upside Nov 27, 2019 · See the AKBA stock analysis. Aerie Pharmaceuticals (AERI) While Bernardino’s forecast implies huge upside potential, based on the $23 average price target the Street sees even more. We’re Akebia Therapeutics Stock Forecast | AKBA Stock Predictions
AKBA / Akebia Therapeutics, Inc. - Institutional Ownership and Shareholders File Date, Form, Investor, Opt, Avg Share Price, Shares, Shares Changed
Different price, presumably because of currency values, but both price charts track one another. OTC also has a larger public float by about 25%, but total AKBA - Akebia Therapeutics Inc Stock quote - CNNMoney.com Find real-time AKBA - Akebia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. AKBA Stock Price, Forecast & News (Akebia Therapeutics) Researching Akebia Therapeutics (NASDAQ:AKBA) stock? View AKBA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Akebia Therapeutics, Inc. Common Stock (AKBA) Earnings ... Find the latest Earnings Report Date for Akebia Therapeutics, Inc. Common Stock (AKBA) at Nasdaq.com. Looking for additional market data? the consensus EPS forecast for the quarter is $-0.44
Based on 5 analysts offering 12 month price targets for Akebia Therapeutics in the last 3 months. The average price target is $13.80 with a high forecast of
Real time Akebia Therapeutics (AKBA) stock price quote, stock graph, news & analysis. Real time Akebia Therapeutics (AKBA) stock price quote, stock graph, news & analysis. Akebia Therapeutics Inc., AKBA Quick Chart - (NAS) AKBA ...
View Akebia Therapeutics' (NASDAQ:AKBA) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. View Akebia Therapeutics' (NASDAQ:AKBA) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. stock lists and powerful research tools
Find the latest Akebia Therapeutics, Inc. (AKBA) stock quote, history, news and other vital information to help you with your stock trading and investing. Buy or Sell AKBA (Akebia Therapeutics) stocks (forecast)? Dec 20, 2019 · AKBA Forecast and Technical Stock Analysis Hold candidate since 2019-12-18 Loss -0.96% PDF Akebia Therapeutics fell by -0.80% in the last day ( Friday, 20th Dec 2019 ) from $6.23 to $6.18 and has now fallen 5 days in a row. During the day the stock fluctuated 3.48% from a day low at $6.03 to a day high of $6.24. The price has been going up and AKBA Earnings Date, Forecast and Report (Akebia Therapeutics) View Akebia Therapeutics' (NASDAQ:AKBA) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. View Akebia Therapeutics' (NASDAQ:AKBA) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. stock lists and powerful research tools KALA - Kala Pharmaceuticals Inc Stock quote - CNNMoney.com
Mar 10, 2020 · Akebia Therapeutics, Inc. Common Stock (AKBA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Buy or Sell AKBA (Akebia Therapeutics) stocks (forecast)? Dec 20, 2019 · AKBA Forecast and Technical Stock Analysis Hold candidate since 2019-12-18 Loss -0.96% PDF Akebia Therapeutics fell by -0.80% in the last day ( Friday, 20th Dec 2019 ) from $6.23 to $6.18 and has now fallen 5 days in a row. During the day the stock fluctuated 3.48% from a day low at $6.03 to a day high of $6.24. The price has been going up and
AKBA / Akebia Therapeutics, Inc. 424B5 - Prospectus - 424B5. 03-12 sec.gov 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-223585 CALCULATION OF REGISTRATION FEE Title of Securities to be Registered Proposed Maximum Aggregate Offering Price Amount of Registration Fee(1) Common Stock, $0.00001 par value per share $65,000,000 $8,437 (1) The filing fee of $8,437 is AGEN Agenus Inc. — Stock Price and Discussion | Stocktwits Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. AKBA Short Interest / Akebia Therapeutics, Inc.